Nicholas Investment Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-30,552
| Closed | -$4.77M | – | 189 |
|
|
2022
Q2 | $4.77M | Buy |
+30,552
| New | +$4.77M | 0.45% | 84 |
|
|
2018
Q4 | – | Sell |
-19,450
| Closed | -$3.27M | – | 230 |
|
|
2018
Q3 | $3.27M | Sell |
19,450
-1,179
| -6% | -$198K | 0.26% | 150 |
|
|
2018
Q2 | $3.55M | Buy |
20,629
+1,734
| +9% | +$299K | 0.25% | 132 |
|
|
2018
Q1 | $2.85M | Buy |
18,895
+1,541
| +9% | +$233K | 0.2% | 160 |
|
|
2017
Q4 | $2.34M | Sell |
17,354
-4,621
| -21% | -$622K | 0.15% | 193 |
|
|
2017
Q3 | $3.21M | Sell |
21,975
-275
| -1% | -$40.2K | 0.22% | 158 |
|
|
2017
Q2 | $3.46M | Buy |
22,250
+174
| +0.8% | +$27.1K | 0.24% | 146 |
|
|
2017
Q1 | $3.2M | Buy |
+22,076
| New | +$3.2M | 0.23% | 164 |
|
|
2016
Q4 | – | Sell |
-29,954
| Closed | -$3.64M | – | 312 |
|
|
2016
Q3 | $3.64M | Sell |
29,954
-750
| -2% | -$91.1K | 0.24% | 165 |
|
|
2016
Q2 | $4.34M | Buy |
30,704
+20,309
| +195% | +$2.87M | 0.3% | 123 |
|
|
2016
Q1 | $1.36M | Sell |
10,395
-3,173
| -23% | -$414K | 0.1% | 264 |
|
|
2015
Q4 | $1.91M | Sell |
13,568
-900
| -6% | -$126K | 0.13% | 259 |
|
|
2015
Q3 | $1.92M | Sell |
14,468
-124
| -0.8% | -$16.5K | 0.14% | 249 |
|
|
2015
Q2 | $2.57M | Sell |
14,592
-15,700
| -52% | -$2.76M | 0.16% | 234 |
|
|
2015
Q1 | $5.23M | Sell |
30,292
-84
| -0.3% | -$14.5K | 0.33% | 101 |
|
|
2014
Q4 | $4.97M | Buy |
30,376
+29
| +0.1% | +$4.75K | 0.31% | 123 |
|
|
2014
Q3 | $4.87M | Buy |
+30,347
| New | +$4.87M | 0.3% | 99 |
|
|
2014
Q1 | – | Sell |
-21,736
| Closed | -$2.75M | – | 309 |
|
|
2013
Q4 | $2.75M | Sell |
21,736
-11,995
| -36% | -$1.52M | 0.21% | 130 |
|
|
2013
Q3 | $3.1M | Buy |
33,731
+7,764
| +30% | +$714K | 0.26% | 101 |
|
|
2013
Q2 | $1.79M | Buy |
+25,967
| New | +$1.79M | 0.17% | 207 |
|